Abigail Burroughs, seen here before cancer ravaged her body, died at age 21 after pleading unsuccessfully to use a promising drug called Erbitux, then in final clinical trials but not yet approved by the FDA. Months after Abigail's death, the FDA granted approval amid geysers of self-laudatory praise for making the "life-saving" drug available. Rather than tracking down and beating the tax-fattened bureaucrats who helped kill his daughter – as he was morally entitled to do – Abigail's father Frank created the Abigail Alliance for Better Access to Developmental Drugs.
It's not that often that we can say with perfect confidence that a judicial ruling will lead directly to the needless agonizing deaths of innocent people. The U.S. Court of Appeals for Washington, D.C. handed down just such a ruling (.pdf) in a case brought against the FDA by the Abigail Alliance for Better Access to Developmental Drugs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.